U.S. Synthetic Biology Market Size & Outlook, 2026-2033
- Biotechnology
- Recombinant DNA & DNA Analysis
- Synthetic Biology Market Outlook
- Recombinant DNA & DNA Analysis
Global Market
Related Markets
Ask a question about the synthetic biology market
U.S. synthetic biology market highlights
- The U.S. synthetic biology market generated a revenue of USD 7,327.2 million in 2025 and is expected to reach USD 26,981.9 million by 2033.
- The U.S. market is expected to grow at a CAGR of 17.7% from 2026 to 2033.
- In terms of segment, pcr technology was the largest revenue generating technology in 2025.
- PCR Technology is the most lucrative technology segment registering the fastest growth during the forecast period.
Synthetic biology market data book summary
| Market revenue in 2025 | USD 7,327.2 million |
| Market revenue in 2033 | USD 26,981.9 million |
| Growth rate | 17.7% (CAGR from 2026 to 2033) |
| Largest segment | Pcr technology |
| Fastest growing segment | PCR Technology |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | PCR Technology, Genome Editing Technology, NGS Technology, Bioprocessing Technology, Other Technologies |
| Key market players worldwide | Basf SE, Codexis Inc, Illumina Inc, Merck KGaA, New England Biolabs, Eurofins Scientific SE, Novozymes, DNAstar, Synthego, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 38.7% of the global synthetic biology market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. synthetic biology market is projected to lead the regional market in terms of revenue in 2033.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 26,981.9 million by 2033.
The U.S. is leading synthetic biology as well as biomedical &biotechnology research space. The U.S. synthetic biology market is majorly driven by high investment in the private sector. These investments are expected to lead to introduction of at least new 100 products in the U.S. market in the coming years.
The company will focus on expansion of research & development activities through this investment. In addition, in November 2020, Sumitomo Chemical launched SynBio Hub, a new organization which will focus on accelerating next-generation synthetic biology business in the U.S.
No credit card required*
Publish Date: Feb 21, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Synthetic Biology Market Scope
Synthetic Biology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Basf SE | View profile | 111,855 | Carl-Bosch-Strasse 38, Ludwigshafen am Rhein, Germany, 67056 | www.basf.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Eurofins Scientific SE | View profile | 61,798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | www.eurofins.com |
| New England Biolabs | View profile | 501-1000 | Ipswich, Massachusetts, United States, North America | neb.com |
| DNAstar | View profile | 51-100 | Madison, Wisconsin, United States, North America | www.dnastar.com |
| Codexis Inc | View profile | 174 | 200 Penobscot Drive, Redwood, CA, United States, 94063 | www.codexis.com |
| Synthego | View profile | 251-500 | Redwood City, California, United States, North America | www.synthego.com |
| Novozymes | View profile | 5001-10000 | Bagsværd, Hovedstaden, Denmark, Europe | www.novozymes.com/en# |
U.S. Synthetic Biology Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Synthetic Biology Market Outlook will help companies and investors design strategic landscapes.
Pcr Technology was the largest segment with a revenue share of 35.98% in 2025.
Horizon Databook has segmented the U.S. synthetic biology market based on pcr technology, genome editing technology, ngs technology, bioprocessing technology, other technologies covering the revenue growth of each sub-segment from 2021 to 2033.
The U.S. is leading synthetic biology as well as biomedical &biotechnology research space. The U.S. synthetic biology market is majorly driven by high investment in the private sector. These investments are expected to lead to introduction of at least new 100 products in the U.S. market in the coming years.
The company will focus on expansion of research & development activities through this investment. In addition, in November 2020, Sumitomo Chemical launched SynBio Hub, a new organization which will focus on accelerating next-generation synthetic biology business in the U.S.
- U.S. Synthetic Biology Market Technology Outlook (Revenue, USD Million , 2021-2033)
- PCR Technology
- Genome Editing Technology
- NGS Technology
- Bioprocessing Technology
- Other Technologies
- U.S. Synthetic Biology Market Product Outlook (Revenue, USD Million , 2021-2033)
- Enzymes
- Oligonucleotide/Oligo Pools and Synthetic DNA
- Cloning Technologies Kits
- Xeno-Nucleic Acids
- Chassis Organism
- U.S. Synthetic Biology Market Application Outlook (Revenue, USD Million , 2021-2033)
- Healthcare
- Non-healthcare
- U.S. Synthetic Biology Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Biotechnology and Pharmaceutical companies
- Academic and Government Research Institutes
- Others
Reasons to subscribe to Synthetic Biology Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Synthetic Biology Market Outlook databook
- Our clientele includes a mix of Synthetic Biology Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Synthetic Biology Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Synthetic Biology Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.S. Synthetic Biology Market, 2021-2033 (US$M)
U.S. synthetic biology market statistics, by technology, 2021-2033 (US$M)
